Cargando…

Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients

(1) Background: Therapeutic blocking of the interaction between programmed death-1 (PD-1) with its ligand PD-L1, an immune checkpoint, is a promising approach to restore the antitumor immune response. Improved clinical outcomes have been shown in different human cancers, including non-small cell lun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berghmans, Eline, Jacobs, Julie, Deben, Christophe, Hermans, Christophe, Broeckx, Glenn, Smits, Evelien, Maes, Evelyne, Raskin, Jo, Pauwels, Patrick, Baggerman, Geert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225984/ https://www.ncbi.nlm.nih.gov/pubmed/32252405 http://dx.doi.org/10.3390/cancers12040863

Ejemplares similares

Implementation of MALDI Mass Spectrometry Imaging in Cancer Proteomics Research: Applications and Challenges
por: Berghmans, Eline, et al.
Publicado: (2020)

MALDI Mass Spectrometry Imaging Linked with Top-Down Proteomics as a Tool to Study the Non-Small-Cell Lung Cancer Tumor Microenvironment
por: Berghmans, Eline, et al.
Publicado: (2019)

Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer
por: Jacobs, Julie, et al.
Publicado: (2015)

Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy
por: Jacobs, Julie, et al.
Publicado: (2017)

FACS-Based Proteomics Enables Profiling of Proteins in Rare Cell Populations
por: Maes, Evelyne, et al.
Publicado: (2020)

Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
por: Deben, Christophe, et al.
Publicado: (2018)

Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects
por: Van Loenhout, Jinthe, et al.
Publicado: (2020)

Expression of SARS-CoV-2-Related Surface Proteins in Non-Small-Cell Lung Cancer Patients and the Influence of Standard of Care Therapy
por: Deben, Christophe, et al.
Publicado: (2022)

The Influence of Cell Type and Culture Medium on Determining Cancer Selectivity of Cold Atmospheric Plasma Treatment
por: Biscop, Eline, et al.
Publicado: (2019)

Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy—The Role of Liquid Biopsy in Unraveling the Puzzle
por: Augustus, Elien, et al.
Publicado: (2021)

Determination of the Potential Tumor-Suppressive Effects of Gsdme in a Chemically Induced and in a Genetically Modified Intestinal Cancer Mouse Model
por: Croes, Lieselot, et al.
Publicado: (2019)

Determination of Variation Parameters as a Crucial Step in Designing TMT-Based Clinical Proteomics Experiments
por: Maes, Evelyne, et al.
Publicado: (2015)

In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53
por: Van den Bossche, Jolien, et al.
Publicado: (2019)

Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers
por: Freire Boullosa, Laurie, et al.
Publicado: (2023)

Ultrafiltration and size exclusion chromatography combined with asymmetrical-flow field-flow fractionation for the isolation and characterisation of extracellular vesicles from urine
por: Oeyen, Eline, et al.
Publicado: (2018)

Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma
por: Van Loenhout, Jinthe, et al.
Publicado: (2021)

Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model
por: Freire Boullosa, Laurie, et al.
Publicado: (2022)

Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia
por: Van den Bossche, Jolien, et al.
Publicado: (2017)

Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma
por: Rovers, Sophie, et al.
Publicado: (2022)

Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer
por: Flieswasser, Tal, et al.
Publicado: (2023)

Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect
por: Jacobs, Julie, et al.
Publicado: (2015)

Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer
por: Freire Boullosa, Laurie, et al.
Publicado: (2021)

Processing of Neutrophil α-Defensins Does Not Rely on Serine Proteases In Vivo
por: Glenthøj, Andreas, et al.
Publicado: (2015)

Human Neutrophil Defensins Disrupt Liver Interendothelial Junctions and Aggravate Sepsis
por: Chen, QiXing, et al.
Publicado: (2022)

Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer
por: Domen, Andreas, et al.
Publicado: (2021)

A combined strategy of neuropeptide prediction and tandem mass spectrometry identifies evolutionarily conserved ancient neuropeptides in the sea anemone Nematostella vectensis
por: Hayakawa, Eisuke, et al.
Publicado: (2019)

Fragmentation of Human Neutrophil α-Defensin 4 to Combat Multidrug Resistant Bacteria
por: Ehmann, Dirk, et al.
Publicado: (2020)

Human Neutrophil α-Defensins 1–3 Are Upregulated in the Microenvironment of Fibrotic Liver
por: Abu Fanne, Rami, et al.
Publicado: (2023)

Identification of Non-Canonical Translation Products in C. elegans Using Tandem Mass Spectrometry
por: Parmar, Bhavesh S., et al.
Publicado: (2021)

Characterization of acquired nutlin-3 resistant non-small cell lung cancer cells
por: Deben, Christophe, et al.
Publicado: (2021)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening
por: Deben, Christophe, et al.
Publicado: (2022)

Oviduct-Specific Expression of Human Neutrophil Defensin 4 in Lentivirally Generated Transgenic Chickens
por: Liu, Tongxin, et al.
Publicado: (2015)

Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept
por: Berghmans, Thierry, et al.
Publicado: (2020)

Defensins and Sepsis
por: Xie, Guo-Hao, et al.
Publicado: (2014)

Avian defensins
por: van Dijk, Albert, et al.
Publicado: (2008)

Motor inhibition efficiency in healthy aging: the role of γ-aminobutyric acid
por: Pauwels, Lisa, et al.
Publicado: (2019)

Salivary peptide human neutrophil defensin1–3 and its relationship with early childhood caries
por: Jayakaran, Trophimus Gnanabagyan, et al.
Publicado: (2020)

MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients
por: Deben, Christophe, et al.
Publicado: (2017)

The immune microenvironment characterisation and dynamics in hormone receptor–positive breast cancer before and after neoadjuvant endocrine therapy
por: Oner, Gizem, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iuhjrfe056hbm5kj3cfahgo3ol